Vial Provider Comparison
Blue Sky Peptide vs SwissChems
Same category. Different operational transparency.
Blue Sky Peptide
Grey Market VendorUSE CAUTION
64/ 100
Vial Trust Score
SwissChems
Grey Market VendorUSE CAUTION
65/ 100
Vial Trust Score
SignalBlue Sky PeptideSwissChems
Pharmacy Disclosure
Do they name their pharmacy partner?
✕No pharmacy partner named
✕No pharmacy partner named
Physician Oversight
Are prescribing clinicians named?
✕No clinician disclosure
✕No clinician disclosure
Pricing Transparency
Is pricing shown before signup?
✓Public pricing (Mid)
✓Public pricing (Mid)
Federal Enforcement History
Any FDA, DEA, or OIG actions?
✓No federal actions found
✓No federal actions found
State Availability
How widely is care available?
✕Coverage not disclosed
✕Coverage not disclosed
Membership Model
Is a paid membership required?
✓No membership required
✓No membership required
Data & Privacy
Any reported HIPAA breaches?
✓No breaches on record
✓No breaches on record
Less disclosure
Blue Sky Peptide
Gaps in pharmacy disclosure, physician oversight, and state availability.
More disclosure
SwissChems
Holds the broader public record across the signals Vial tracks.
Updated May 26, 2026
Scores based on operational, compliance, and transparency signals tracked by Vial.
Found this helpful? Share it.
Help others get informed.
Other matchups
Related comparisons
64Blue Sky Peptide
65Direct Peptides
1-point gapSee the gap →
65Direct Peptides
65SwissChems
Same scoreSee the gap →
64Blue Sky Peptide
64Hallandale Health
Same scoreSee the gap →
64Hallandale Health
65SwissChems
1-point gapSee the gap →
64Blue Sky Peptide
64Pinnacle Peptides
Same scoreSee the gap →
64Pinnacle Peptides
65SwissChems
1-point gapSee the gap →